Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Negrier, S.; Huang, X.; Kim, S. T.; Chen, I.; Motzer, R. J. |
| Abstract Title: | Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 256s |
| Language: | English |
| ACCESSION: | WOS:000208457401871 |
| DOI: | 10.1200/jco.2008.26.15_suppl.5024 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5024 -- Source: Wos |
